Trial
NCT04686786
An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
AbbVie
Collaborators
—
Condition
Seizures
Intervention
CVL-865
Why stopped
Closed early after CVL-865-SZ-001 (NCT04244175) did not meet its primary objective
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-11